MedPath

Albireo Pharma, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
130
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

FDA:1

Drug Approvals

BYLVAY

Approval Date
Jun 15, 2023
FDA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath